Purdue Pharma LP - Strategic SWOT Analysis Review
Purdue Pharma LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Purdue Pharma LP (Purdue) is a pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) medicines and related healthcare products. Its major product categories include prescription opioids, sedatives for sleep disorders, laxatives, antiseptics and dietary supplements. The company also conducts clinical studies on new investigational drugs and pharmaceuticals on the market. The company operates facilities in North Carolina and New Jersey. Purdue is headquartered in Stamford, Connecticut, the US.
Purdue Pharma LP Key Recent Developments
Sep 03,2021: Confirmed Plan of Reorganization facilitates creation of new company – “Knoa Pharma”
Sep 01,2021: Plan of Reorganization of Purdue Pharma receives Bankruptcy Court approval
Jul 27,2021: Purdue Pharma announces preliminary voting results on plan of reorganization
Jul 09,2021: Purdue Pharma to pay $4.5bn to settle opioid lawsuit in the US
Jun 03,2021: Purdue Pharma to Begin Soliciting Votes for its Broadly Supported Chapter 11 Plan of Reorganization
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Purdue Pharma LP (Purdue) is a pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) medicines and related healthcare products. Its major product categories include prescription opioids, sedatives for sleep disorders, laxatives, antiseptics and dietary supplements. The company also conducts clinical studies on new investigational drugs and pharmaceuticals on the market. The company operates facilities in North Carolina and New Jersey. Purdue is headquartered in Stamford, Connecticut, the US.
Purdue Pharma LP Key Recent Developments
Sep 03,2021: Confirmed Plan of Reorganization facilitates creation of new company – “Knoa Pharma”
Sep 01,2021: Plan of Reorganization of Purdue Pharma receives Bankruptcy Court approval
Jul 27,2021: Purdue Pharma announces preliminary voting results on plan of reorganization
Jul 09,2021: Purdue Pharma to pay $4.5bn to settle opioid lawsuit in the US
Jun 03,2021: Purdue Pharma to Begin Soliciting Votes for its Broadly Supported Chapter 11 Plan of Reorganization
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
SECTION 1 - ABOUT THE COMPANY
Purdue Pharma LP - Key Facts
Purdue Pharma LP - Key Employees
Purdue Pharma LP - Key Employee Biographies
Purdue Pharma LP - Major Products and Services
Purdue Pharma LP - History
Purdue Pharma LP - Company Statement
Purdue Pharma LP - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Purdue Pharma LP - Business Description
Purdue Pharma LP - Corporate Strategy
Purdue Pharma LP - SWOT Analysis
SWOT Analysis - Overview
Purdue Pharma LP - Strengths
Purdue Pharma LP - Weaknesses
Purdue Pharma LP - Opportunities
Purdue Pharma LP - Threats
Purdue Pharma LP - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Purdue Pharma LP, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Sep 03, 2021: Confirmed Plan of Reorganization facilitates creation of new company – “Knoa Pharma”
Sep 01, 2021: Plan of Reorganization of Purdue Pharma receives Bankruptcy Court approval
Jul 27, 2021: Purdue Pharma announces preliminary voting results on plan of reorganization
Jul 09, 2021: Purdue Pharma to pay $4.5bn to settle opioid lawsuit in the US
Jun 03, 2021: Purdue Pharma to Begin Soliciting Votes for its Broadly Supported Chapter 11 Plan of Reorganization
Mar 15, 2021: Purdue Pharma files broadly supported plan of reorganization
Mar 01, 2021: Former Montana Governor Steve Bullock to monitor Purdue’s compliance with voluntary injunction
Feb 08, 2021: Purdue Pharma’s Avrio Health launches Betadine antiseptic oral rinse for professional use
Oct 22, 2020: Purdue Pharma reaches agreement with DOJ over opioid medicines
Oct 21, 2020: Justice Department announces global resolution of criminal and civil investigations with opioid manufacturer Purdue Pharma and civil settlement with members of the Sackler Family
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
Purdue Pharma LP - Key Facts
Purdue Pharma LP - Key Employees
Purdue Pharma LP - Key Employee Biographies
Purdue Pharma LP - Major Products and Services
Purdue Pharma LP - History
Purdue Pharma LP - Company Statement
Purdue Pharma LP - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Purdue Pharma LP - Business Description
Purdue Pharma LP - Corporate Strategy
Purdue Pharma LP - SWOT Analysis
SWOT Analysis - Overview
Purdue Pharma LP - Strengths
Purdue Pharma LP - Weaknesses
Purdue Pharma LP - Opportunities
Purdue Pharma LP - Threats
Purdue Pharma LP - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Purdue Pharma LP, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Sep 03, 2021: Confirmed Plan of Reorganization facilitates creation of new company – “Knoa Pharma”
Sep 01, 2021: Plan of Reorganization of Purdue Pharma receives Bankruptcy Court approval
Jul 27, 2021: Purdue Pharma announces preliminary voting results on plan of reorganization
Jul 09, 2021: Purdue Pharma to pay $4.5bn to settle opioid lawsuit in the US
Jun 03, 2021: Purdue Pharma to Begin Soliciting Votes for its Broadly Supported Chapter 11 Plan of Reorganization
Mar 15, 2021: Purdue Pharma files broadly supported plan of reorganization
Mar 01, 2021: Former Montana Governor Steve Bullock to monitor Purdue’s compliance with voluntary injunction
Feb 08, 2021: Purdue Pharma’s Avrio Health launches Betadine antiseptic oral rinse for professional use
Oct 22, 2020: Purdue Pharma reaches agreement with DOJ over opioid medicines
Oct 21, 2020: Justice Department announces global resolution of criminal and civil investigations with opioid manufacturer Purdue Pharma and civil settlement with members of the Sackler Family
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Purdue Pharma LP, Key Facts
Purdue Pharma LP, Key Employees
Purdue Pharma LP, Key Employee Biographies
Purdue Pharma LP, Major Products and Services
Purdue Pharma LP, History
Purdue Pharma LP, Other Locations
Purdue Pharma LP, Subsidiaries
Purdue Pharma LP, Key Competitors
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Purdue Pharma LP, Recent Deals Summary
Purdue Pharma LP, Key Facts
Purdue Pharma LP, Key Employees
Purdue Pharma LP, Key Employee Biographies
Purdue Pharma LP, Major Products and Services
Purdue Pharma LP, History
Purdue Pharma LP, Other Locations
Purdue Pharma LP, Subsidiaries
Purdue Pharma LP, Key Competitors
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Purdue Pharma LP, Recent Deals Summary
LIST OF FIGURES
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021